Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"denosumab"”.
-
Challenges in the Pharmacokinetics of Therapeutic Proteins
… performed with two model drugs: filgrastim and denosumab. Their published structural pharmacokinetic models and model parameters were employed in the simulations of plasma concentration-time profiles at different IV and SC doses. The bioavailability was calculated as the ratio of dose-normalized …
-
Medication-Related osteonecrosis of the jaw in women with breast cancer. a literature review /
… to bone metastases. Bisphosphonates (BPs) and Denosumab (DNB) are key bone-modifying agents (BMAs) used to target bone metabolism, reduce metastatic risk, and enhance adjuvant therapy efficacy in early-stage breast cancer. However, the usage of these agents carries risks, including adverse …
-
Καταγματικός κίνδυνος σε ενηλίκους με κακοήθειες
… φάρμακα όπως τα διφωσφονικά και denosumab. Συμπεράσματα Ο κίνδυνος κατάγματος σε ασθενείς με καρκίνο επηρεάζεται από διάφορους παρά¬γοντες, όπως ο τύπος του καρκίνου, το στάδιο της νόσου, οι αντικαρκινικές θεραπείες, η κατάσταση της υγείας των οστών και η παρουσία οστικών …
-
An assessment of the oral health status and dental treatment needs of oncology patients receiving bone modifying agents
… and 6% (n=8) were planned for subcutaneous (SC) denosumab. 37 patients were current smokers (24.7%), and 23 patients were ex-smokers (15.3%). 65 patients (43.3%) did not have a general dental practitioner (GDP) at the time of presentation and 76 patients (50%) had a dental presenting complaint, …
-
Targeting Cox-2 and Rank In Aggressive Breast Cancers: Inflammatory Breast Cancer and Triple-Negative Breast Cancer
<p>Inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) are two highly aggressive breast cancer subtypes associated with a poor outcome. Despite sensitivity to current treatment, these breast cancers subtypes have a high recurrence rate and proclivity to metastasize early. The …